AF
VRCA icon

Amalgamated Financial’s Verrica Pharmaceuticals VRCA Stock Holding History

Amalgamated Financial’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$17K Buy
+213
New +$17.6K ﹤0.01% 2791

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amalgamated Financial's VRCA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Verrica Pharmaceuticals (VRCA) in Q1 2022: 213 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #2791 among its holdings.

51 funds tracked by Wall St. Rank hold VRCA as of Q1 2022.

  • Amalgamated Financial held 213 shares of Verrica Pharmaceuticals worth $17K as of Q1 2022.
  • Verrica Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
  • Verrica Pharmaceuticals made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2791 holding.
  • 51 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.